- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| So | VITURA HEALTH LIMITED: Cortexa advances commercialisation of MDMA supply | - | ASX | ||
| 17.03. | Vitura Health Signs Online Distribution Deal for MedReleaf Medicinal Cannabis Products | 2 | smallcaps.com.au | ||
| 16.03. | VITURA HEALTH LIMITED: VIT enters distribution agreement with MedReleaf Australia | - | ASX | ||
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| 12.03. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Investor Presentation | 2 | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Results Release | 1 | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Results Investor Webinar | 3 | ASX | ||
| 25.02. | VITURA HEALTH LIMITED: H1 FY26 Appendix 4D and Half Year Report | 2 | ASX | ||
| 23.02. | VITURA HEALTH LIMITED: Revised Trading Policy | 3 | ASX | ||
| 03.02. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | 1 | ASX | ||
| 28.01. | VITURA HEALTH LIMITED: CEO Transition and Interim Leadership Update | - | ASX | ||
| 11.01. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 09.01. | VITURA HEALTH LIMITED: Appointment of Chief Financial Officer | 3 | ASX | ||
| 05.01. | VITURA HEALTH LIMITED: Amended Constitution - Late Lodgement | - | ASX | ||
| 05.01. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 23.12.25 | VITURA HEALTH LIMITED: Change of Director's Interest Notice - Late Lodgement | 1 | ASX | ||
| 17.12.25 | VITURA HEALTH LIMITED: Change of Company Secretary | - | ASX | ||
| 01.12.25 | VITURA HEALTH LIMITED: Industry Advisory Group Charter | 2 | ASX | ||
| 26.11.25 | VITURA HEALTH LIMITED: Results of 2025 Annual General Meeting | 1 | ASX | ||
| 25.11.25 | VITURA HEALTH LIMITED: 2025 AGM presentation | - | ASX |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 2,850 | +0,88 % | K-Tech Solutions Company Limited Announces Joint Venture with Aurora AZ Energy Ltd. to Develop up to 500 MW of AI and HPC Infrastructure in Canada | HONG KONG and NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- K-Tech Solutions Company Limited (Nasdaq: KMRK) ("K-Tech" or the "Company"), a technology firm specializing in high-performance computing infrastructure... ► Artikel lesen | |
| TILRAY BRANDS | 5,450 | +1,30 % | Monday newspaper round-up: Palantir, BrewDog, Darktrace | ||
| ORGANIGRAM GLOBAL | 1,170 | +2,63 % | Organigram Global Inc: Organigram garners ISS support for Sanity transaction | ||
| SNDL | 1,145 | -2,30 % | SNDL Inc.: SNDL Reports Fourth Quarter and Full Year 2025 Financial and Operational Results | EDMONTON, Alberta, March 12, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the full year and fourth quarter... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 1,170 | 0,00 % | XFRA 0NF1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| WAYLAND GROUP | - | - | EQS-News: Berger Montague (Canada) PC: Ankündigung der Anhörung zur Genehmigung des Vergleichs - Wayland Group Corp., Scott Langille, Gerhard Müller, Paul Pathak, Eric Silver, M. Stein, John Does 1-3, Canaccord Genuity Corp. und RF Securities Clearing LP | EQS-News: Berger Montague (Canada) PC
/ Schlagwort(e): Rechtssache/Sonstiges
ANKÜNDIGUNG DER ANHÖRUNG ZUR GENEHMIGUNG DES VERGLEICHS - KURZFASSUNG - WAYLAND... ► Artikel lesen | |
| BIONANO GENOMICS | 1,440 | 0,00 % | Bionano Genomics: Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 | SAN DIEGO, March 23, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 13,400 | +3,08 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026 | ||
| HIGH TIDE | 1,984 | +1,74 % | High Tide meldet die Finanzergebnisse des ersten Quartals 2026 mit einem Rekordumsatz von mehr als 700 Mio. $ auf annualisierter Basis | Canna Cabana ist mit aktuell 220 Geschäftsstandorten weiterhin der größte Cannabiseinzelhändler in Kanada
Das Unternehmen bekräftigt sein langfristiges Ziel von mehr als 350 Standorten... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 3,285 | -5,60 % | Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates | Achieve also Announces Partnership with U.S.-based Adare Pharma Solutions for Cytisinicline Manufacturing Conference Call Scheduled for 8:30 AM EDT Today, March 24, 2026 SEATTLE and VANCOUVER, British... ► Artikel lesen | |
| JAGUAR HEALTH | 0,410 | 0,00 % | Jaguar Health, Inc.: FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease | MVID has a lethal natural history requiring life-sustaining parenteral support (PS), which includes total parenteral nutrition (TPN), which is associated with significant toxicities; PS reduction could... ► Artikel lesen | |
| MEDIPHARM LABS | 0,039 | -1,02 % | MediPharm Labs Corp.: MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO | TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,020 | -2,44 % | ARGENT BIOPHARMA LIMITED: s708A Cleansing Notice | ||
| AYR WELLNESS | 0,078 | -100,00 % | XFRA 3KJB: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAYR WELLNESS INC.RES.VTG.... ► Artikel lesen |
Das Unternehmen VITURA HEALTH LIMITED kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,020 Euro und damit +11,43 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.